š”š²šš š¦ššŗšŗš®šæš
ā¢ Zydus Lifesciences reported a 5.66% increase in net sales and a 53.24% increase in net profit for the September 2023 quarter.
ā¢ EBITDA also saw a significant increase of 39.6%.
ā¢ The company's EPS has increased from Rs. 5.15 to Rs. 7.91 in the same period.